Polar Capital Funds PLC - Polar Capital Healthcare Opportunities Fund Fonds
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Eli Lilly and Co | US5324571083 | 8,81% |
| Enliven Therapeutics Inc | US29337E1029 | 7,93% |
| argenx SE | NL0010832176 | 6,05% |
| Teva Pharmaceutical Industries Ltd ADR | US8816242098 | 5,67% |
| Novartis AG Registered Shares | CH0012005267 | 5,41% |
| Johnson & Johnson | US4781601046 | 5,05% |
| Torrent Pharmaceuticals Ltd | INE685A01028 | 4,86% |
| Xenon Pharmaceuticals Inc | CA98420N1050 | 4,42% |
| Cytokinetics Inc | US23282W6057 | 3,93% |
| Uniphar PLC | IE00BJ5FQX74 | 3,70% |
| Sonstige | 44,17% |